APL is a leading Scandinavian Contract Development and Manufacturing Organisation (CDMO) in the Life Science sector, dedicated to the development, manufacturing, and analysis of pharmaceuticals. The company’s mission is to manufacture personalised medicines tailored to patients with specific needs. With a workforce of approximately 550 employees across four production facilities in Sweden, APL contributes to an annual turnover of about 150 million euros. As a 100% state-owned enterprise, APL integrates its CDMO offerings with public policy assignments to support the development and manufacturing of extemporaneous products for the Swedish population.

Services include:
- Contract Development and Manufacturing (CDMO)
- Laboratory and Analytical Services
- Small Molecule
- Medical Devices
- Drug Product Formulation (FDF)
- Research & Development
- Clinical Trial Materials
- Packaging
- Analytical Methods Development
- Regulatory Services
- Solid Dosage
- Clinical Dose
- Clinical Packaging
- Analytical Services
- Non Sterile Dosage
- Injectables

APL remains committed to excellence in the pharmaceutical sector, driven by its mission to provide high-quality, personalised healthcare solutions. For more information, please visit apl.se.